122 related articles for article (PubMed ID: 7581125)
1. Induction of cutaneous 'graft-versus-host like' reaction by recombinant IL-2 after autologous bone marrow transplantation.
Costello R; Blaise D; Jacquemier J; Monges G; Stoppa AM; Viens P; Olive D; Bouabdallah M; Brandely ; Gastaut JA
Bone Marrow Transplant; 1995 Jul; 16(1):199-200. PubMed ID: 7581125
[No Abstract] [Full Text] [Related]
2. Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy.
Massumoto C; Benyunes MC; Sale G; Beauchamp M; York A; Thompson JA; Buckner CD; Fefer A
Bone Marrow Transplant; 1996 Mar; 17(3):351-6. PubMed ID: 8704686
[TBL] [Abstract][Full Text] [Related]
3. Similarity between eruptions induced by sulfhydryl drugs and acute cutaneous graft-versus-host disease after bone marrow transplantation.
Takatsuka H; Takemoto Y; Yamada S; Mori A; Wada H; Fujimori Y; Okamoto T; Kanamaru A; Kakishita E
Hematology; 2002 Feb; 7(1):55-7. PubMed ID: 12171778
[TBL] [Abstract][Full Text] [Related]
4. Skin and stomach graft versus host disease after syngeneic BMT in CML: a case report.
Pelosini M; Galimberti S; Benedetti E; Caracciolo F; Fazzi R; Petrini M; Papineschi F
Leuk Res; 2007 Nov; 31(11):1603-4. PubMed ID: 17328949
[No Abstract] [Full Text] [Related]
5. Cytokine expression in human cutaneous chronic graft-versus-host disease.
Ochs LA; Blazar BR; Roy J; Rest EB; Weisdorf DJ
Bone Marrow Transplant; 1996 Jun; 17(6):1085-92. PubMed ID: 8807119
[TBL] [Abstract][Full Text] [Related]
6. [The skin manifestations of the graft vs. host reaction].
Biriukov AV; Baranov AE; Selidovkin GD; Evseeva LV; Getling ZM; Persina IS
Vestn Dermatol Venerol; 1990; (5):16-9. PubMed ID: 2402935
[TBL] [Abstract][Full Text] [Related]
7. Contrast media triggering cutaneous graft-versus-host disease.
Vavricka SR; Halter J; Furrer K; Wolfensberger U; Schanz U
Bone Marrow Transplant; 2002 Jun; 29(11):899-901. PubMed ID: 12080354
[TBL] [Abstract][Full Text] [Related]
8. The effects of interleukin 10 and interferon gamma cytokine gene polymorphisms on survival after autologous bone marrow transplantation for patients with breast cancer.
Wu JM; Bensen-Kennedy D; Miura Y; Thoburn CJ; Armstrong D; Vogelsang GB; Hess AD
Biol Blood Marrow Transplant; 2005 Jun; 11(6):455-64. PubMed ID: 15931634
[TBL] [Abstract][Full Text] [Related]
9. Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosis factor-alpha in graft-versus-host disease.
Imamura M; Hashino S; Kobayashi H; Kubayashi S; Hirano S; Minagawa T; Tanaka J; Fujii Y; Kobayashi M; Kasai M
Bone Marrow Transplant; 1994 Jun; 13(6):745-51. PubMed ID: 7920309
[TBL] [Abstract][Full Text] [Related]
10. Acquired ichthyosis in bone marrow transplant recipients.
Spelman LJ; Strutton GM; Robertson IM; Weedon D
J Am Acad Dermatol; 1996 Jul; 35(1):17-20. PubMed ID: 8682957
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: role of natural killer T cells.
Liu YP; Li Z; Nador RG; Strober S
Transplantation; 2008 Feb; 85(4):607-14. PubMed ID: 18347541
[TBL] [Abstract][Full Text] [Related]
12. Blockade of acute grade IV skin and eye graft-versus-host disease by anti-interleukin-2 receptor monoclonal antibody in genoidentical bone marrow transplantation setting.
Ozşahin H; Tuchschmid P; Lauener R; Waldvogel K; Nadal D; Seger RA
Turk J Pediatr; 1998; 40(2):231-5. PubMed ID: 9677728
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous chronic graft-versus-host disease localized to the field of total lymphoid irradiation.
Okamoto S; Takahashi S; Inoue T; Tojo A; Tani K; Kikuchi A; Shimizu H; Nishikawa T; Ikeda Y; Asano S
Bone Marrow Transplant; 1996 Jan; 17(1):111-3. PubMed ID: 8673042
[TBL] [Abstract][Full Text] [Related]
14. Cytokine gene expression by concanavalin A-stimulated peripheral mononuclear cells after bone marrow transplantation: an indicator of immunological abnormality due to chronic graft-versus-host disease.
Tanaka J; Imamura M; Kasai M; Zhu X; Kobayashi S; Imai K; Hashino S; Higa T; Sakurada K; Miyazaki T
Bone Marrow Transplant; 1994 Nov; 14(5):695-701. PubMed ID: 7889002
[TBL] [Abstract][Full Text] [Related]
15. Roles of interleukin-10 in acute graft-versus-host disease and graft rejection.
Ju X; Wang J; Xu B; Cao Y; Lü S
Chin Med J (Engl); 2003 Apr; 116(4):534-7. PubMed ID: 12875717
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-2 for prevention of graft-versus-host disease after haploidentical marrow transplantation.
Przepiorka D; Ippoliti C; Koberda J; Chan KW; Khouri IF; Fischer HE; Huh YO; Escudier SM; Seong D; Davis M
Transplantation; 1994 Oct; 58(7):858-60. PubMed ID: 7940725
[No Abstract] [Full Text] [Related]
17. Bath PUVA therapy in pediatric patients with drug-resistant cutaneous graft-versus-host disease.
Bonanomi S; Balduzzi A; Tagliabue A; Biagi E; Rovelli A; Corti P; Crippa D; Uderzo C
Bone Marrow Transplant; 2001 Sep; 28(6):631-2. PubMed ID: 11607781
[No Abstract] [Full Text] [Related]
18. Lichenoid graft-vs-host disease in an autologous bone marrow transplant recipient.
Martin RW; Farmer ER; Altomonte VL; Vogelsang GB; Santos GW
Arch Dermatol; 1995 Mar; 131(3):333-5. PubMed ID: 7887664
[TBL] [Abstract][Full Text] [Related]
19. Soft tissue sarcoma in the setting of chronic cutaneous graft versus host disease after allogenic bone marrow transplantation.
Bylund KC; Giampoli E; Singh D; Doerr T; Sahasrabudhe D; Liesveld J; Constine LS
Cancer Invest; 2008 Jul; 26(6):638-41. PubMed ID: 18584356
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effect of intravenous lidocaine in cutaneous chronic graft-versus-host disease secondary to donor lymphocyte infusion.
Voltarelli JC; Ahmed H; Paton EJ; Stracieri AB; Holman P; Bashey A; Coutinho M; Simoes BP; Ball ED; Carrier E
Bone Marrow Transplant; 2001 Jul; 28(1):97-9. PubMed ID: 11498752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
